Study says recurring C. diff infections up 189% from 2001 to 2012

Findings indicate multiple recurring C. diff infections place an increased burden on healthcare system


Multiple recurring Clostridium difficile infections increased 189 percent from 2001 to 2012, according to an article on the Becker's Infection Control & Clinical Quality website.

In contrast, the incidence of C. diff infections rose by about 43 percent.

Researchers labeled the C. diff infections as "multiple recurrent" when the patients were teated with three courses of antibiotics, with little time between each course.

The study suggested the findings indicate multiple recurring C. diff infections place an increased burden on the healthcare system.

Read the article.

 

 



July 12, 2017


Topic Area: Infection Control


Recent Posts

A Shift in Healthcare Facilities Management

Healthcare facilities leaders who embrace a mindset change will be better prepared for the future.


Trauma-Informed Design Transforms Boston Homeless Shelter

Case study: A comprehensive renovation of St. Francis House makes use of trauma-informed design, infrastructure upgrades and operational improvements.


Inside One of Healthcare's Most Ambitious Hospital Projects 

When someone faces a serious medical condition, having access to world-class care close to home can make all the difference. 


Disinfectant Contact Time: The Case for Biofilm Disruption

Contact time, while essential for compliance, does not reliably predict microbial reduction on actual healthcare surfaces.


Texas HHSC Reaches Construction Milestone for Panhandle State Hospital in Amarillo

Construction is expected to be completed in fall 2027.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.